Cov cuab yeej no ua rau kom muaj kev tuav pov hwm ntawm cov tshuaj muaj txiaj ntsig zoo thaum txhim kho cov khoom ruaj khov. Vim lawv cov ntsiab lus tsis tshua muaj dej noo, lyophilized hmoov txhaj tshuaj zoo txo qhov tsis zoo ntawm ib puag ncig yam xwm txheej-xws li kub, av noo, thiab lub teeb- ntawm cov tshuaj, yog li txuas lub neej txee thiab yooj yim khaws cia thiab thauj. Kev koom ua ke ntawm lyoprotectants (xws li trehalose thiab mannitol), nrog rau kev tswj cov txheej txheem nruj, ua lub luag haujlwm tseem ceeb hauv kev txiav txim siab qhov ua tau zoo ntawm cov txheej txheem lyophilization thiab kev ruaj ntseg ntawm cov khoom kawg.
Hais txog kev siv, lyophilization thev naus laus zis tau pib ua haujlwm los tsim cov khoom cua sov- cov tshuaj rhiab heev, nrog rau cov khoom siv roj ntsha xws li enzymes thiab ntshav. Kev txhaj tshuaj lyophilized feem ntau yog siv rau cov tshuaj tua kab mob tshwj xeeb, peptide- thiab cov protein- cov tshuaj, thiab cov tshuaj tiv thaiv (xws li, cov tshuaj tiv thaiv nyob rau hauv Japanese encephalitis). Hauv kev lag luam tshuaj pleev ib ce, cov thev naus laus zis no yog siv los khaws cov khoom xyaw tsis ruaj khov, xws li peptides thiab Vitamin C; Txawm li cas los xij, raws li cov cai tshaj tawm los ntawm Tuam Tshoj National Medical Products Administration (NMPA), cov khoom tsim nrog - lossis thov kom muaj -Human Oligopeptide-1 (EGF) yog suav tias yog txhaum cai.